RL
Richard Law Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
51%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
47.6%
Neutral
38.1%
Negative
14.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $26 |
4%
downside
| 2 | +197% |
0
%
| 21 Nov ‘25 15 days ago |
|
|
|
Buy
Maintained
| $135 |
23%
upside
| 1 | +1.5% |
0
%
| 18 Nov ‘25 18 days ago |
|
|
|
Neutral
Maintained
| $29 |
7%
downside
| 2 | – |
–
| 30 Oct ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $40 |
14%
downside
| 1 | – |
–
| 26 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $52 |
35%
upside
| 2 | +123% |
0
%
| 9 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $30 |
6%
downside
| 2 | +65% |
0
%
| 7 Aug ‘25 4 months ago |
|
|
|
Buy
Maintained
| $82 |
450%
upside
| 3 | -15% |
0
%
| 6 Aug ‘25 4 months ago |
|
|
|
Sell
Maintained
| $3 |
57%
downside
| 3 | -22% |
0
%
| 9 May ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $13 |
292%
upside
| 2 | – |
–
| 9 May ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $31 |
5%
upside
| 2 | – |
–
| 9 May ‘25 7 months ago |
|
|
|
Neutral
Initiated
| $30 |
22%
downside
| 1 | – |
–
| 8 Apr ‘25 8 months ago |
|